Multifaceted nanolipidic carriers: a modish stratagem accentuating nose-to-brain drug delivery
Source abstract
Abstract
The exponential growth of nanotechnology has focused on therapeutic pursuits, notably for brain disorders. Nanocarriers have submicron particle sizes, typically around 500 nm. Over the past few years, interest in nanostructured lipid carriers as alternative pharmaceutical delivery systems has increased on both the scientific and commercial fronts. It belongs to a more recent incarnation of lipid nanoparticulate systems with a solid matrix and superior room temperature stability. More recently, they have also been used in gene therapy, cancer treatment, and brain targeting. In this review, the uses and significance of nanostructured lipid carriers (NLC) in combating brain diseases have been thoroughly covered, with examples from several recent research papers. A summary of NLCs’ present patent status has been provided to highlight their promising potential. Related patents and research reports associated with this topic are gathered and availed. The paper thoroughly summarizes NLCs and their application in different routes of administration. Drug administration directly to the brain via nose through NLCs is mainly focused. Nose-to-brain delivery has more benefits compared to the other routes. NLCs provide significant advantages such as targeted delivery, less toxicity, higher drug loading capacity due to imperfect structure, etc. However, the particle size of NLCs for intranasal drug delivery should be < 200 nm. Also, NLC is combined with a medical device to achieve the add-on benefits for delivering drugs effectively. According to the comprehensive review of literature and patents like CN110013471B, IN-MUM-2015-00667A, IN202021023420A, and AU2021104270A4, drug-loaded NLCs in nose-to-brain delivery show promising results. NLCs can increase bioavailability and reduce dosing frequency, indirectly reducing dose-related side effects. Intervening NLCs directly on the targeted site displays site specificity and many more benefits than conventional dosage forms. Thus, using NLCs in nose-to-brain drug delivery is invigorating. Graphical abstract
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Liu Y, Wen H, Wu X, Wu M, Liu L, Wang J, … Dan M (2021) The bio-persistence of reversible inflammatory, histological changes and metabolic profile alterations in rat livers after silver/gold nanorod administration. Nanomaterials 11(10). https://doi.org/10.3390/nano1110265610.3390/nano11102656 ↗
2. Ayub A, Wettig S (2022) An overview of nanotechnologies for drug delivery to the brain. Pharmaceutics. https://doi.org/10.3390/pharmaceutics1402022410.3390/pharmaceutics14020224 ↗
3. Gaté L, Disdier C, Cosnier F, Gagnaire F, Devoy J, Saba, W, … Mabondzo A (2017) Biopersistence and translocation to extrapulmonary organs of titanium dioxide nanoparticles after subacute inhalation exposure to aerosol in adult and elderly rats. Toxicol Lett 265:61–69. https://doi.org/10.1016/j.toxlet.2016.11.00910.1016/j.toxlet.2016.11.009 ↗
4. Patel AA, Patel RJ, Mishra P (2021) Nanosuspension for oral delivery of tadalafil: pharmacodynamic and pharmacokinetic studies. J Drug Deliv Sci Technol. 61:102203. https://doi.org/10.1016/j.jddst.2020.10220310.1016/j.jddst.2020.102203 ↗
5. Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine. https://doi.org/10.2147/IJN.S14631510.2147/IJN.S146315 ↗
6. Prajapati JB, Katariya H, Patel R (2018) Peyer’e patch targeting of Isradipine loaded solid lipid nanoparticles: it’s cellular uptake study. J Drug Deliv Sci Technol 43:318–326. https://doi.org/10.1016/j.jddst.2017.10.01710.1016/j.jddst.2017.10.017 ↗
7. Khosa A, Reddi S, Saha RN (2018) Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2018.04.05510.1016/j.biopha.2018.04.055 ↗
8. Haider M, Abdin SM, Kamal L, Orive G (2020) Nanostructured lipid carriers for delivery of chemotherapeutics: a review. Pharmaceutics. https://doi.org/10.3390/pharmaceutics1203028810.3390/pharmaceutics12030288 ↗
9. Patel RJ, Patel ZP (2013) Formulation optimization and evaluation of nanostructured lipid carriers containing valsartan. Int J Pharm Sci Nanotechnol 6(2):2077–2086. https://doi.org/10.37285/ijpsn.2013.6.2.1010.37285/ijpsn.2013.6.2.10 ↗
10. Das S, Ng WK, Tan RBH (2012) Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47(1):139–151. https://doi.org/10.1016/j.ejps.2012.05.01010.1016/j.ejps.2012.05.010 ↗
11. Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Patel RJ, … Alexander A (2020) Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. J Control Release. https://doi.org/10.1016/j.jconrel.2020.02.02010.1016/j.jconrel.2020.02.020 ↗
12. Agrawal M, Saraf S, Pradhan M, Patel RJ, Singhvi G, Ajazuddin Alexander A (2021) Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design. Biomed Pharmacother 141. https://doi.org/10.1016/j.biopha.2021.11191910.1016/j.biopha.2021.111919 ↗
13. Chauhan I, Yasir M, Verma M, Singh AP (2020) Nanostructured lipid carriers: a groundbreaking approach for transdermal drug delivery. Adv Pharm Bull. https://doi.org/10.34172/apb.2020.02110.34172/apb.2020.021 ↗
14. Li Q, Cai T, Huang Y, Xia X, Cole SPC, Cai Y (2017) A review of the structure, preparation, and application of NLCs, PNPs, and PLNs. Nanomaterials. https://doi.org/10.3390/nano706012210.3390/nano7060122 ↗
15. Tekade AR, Mittha PS, Pisal CS (2022) Nanostructured lipid carriers for nose to brain delivery targeting CNS: diversified role of liquid lipids for synergistic action. Adv Pharm Bull. https://doi.org/10.34172/apb.2022.07810.34172/apb.2022.078 ↗
16. Patel R, Yadav BK, Patel G (2022) Progresses in nano-enabled platforms for the treatment of vaginal disorders. Recent Pat Nanotechnol 17(3):208–227. https://doi.org/10.2174/187221051666622062815044710.2174/1872210516666220628150447 ↗
17. Patel R, Shah R, Patel A, Hadiya K, Parmar J, Patel G (2023) Off-Label use of Raloxifene hydrochloride in uterine fibroids: a novel insert-based formulation approach and IN-VIVO preclinical evaluation. J Drug Deliv Sci Technol 84:104552. https://doi.org/10.1016/j.jddst.2023.10455210.1016/j.jddst.2023.104552 ↗
18. Gaba B, Fazil M, Khan S, Ali A, Baboota S, Ali J (2015) Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride. Bull Fac Pharmacy, Cairo Univ 53(2):147–159. https://doi.org/10.1016/j.bfopcu.2015.10.00110.1016/j.bfopcu.2015.10.001 ↗
19. Chandana KV, Gupta NV, Kanna S (2019) Nanostructured lipid carriers: the frontiers in drug delivery. Asian J Pharm Clin Res 8–12. https://doi.org/10.22159/ajpcr.2019.v12i7.3359510.22159/ajpcr.2019.v12i7.33595 ↗
20. Samprasit W, Vasarach C, Opanasopit P, Sriamornsak P, Chamsai B (2022) Topical nanostructured lipid carriers of alpha-mangostin and resveratrol for synergistic antioxidant activity. Pharm Nanotechnol 10. https://doi.org/10.2174/221173851066622042611250810.2174/2211738510666220426112508 ↗
21. Mahmood A, Rapalli VK, Gorantla S, Waghule T, Singhvi G (2022) Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: QbD-driven design, optimization, and in vitro and ex vivo evaluations. Drug Deliv Transl Res 12(5):1118–1135. https://doi.org/10.1007/s13346-021-00986-710.1007/s13346-021-00986-7 ↗
22. Oliveira PM, Alencar-Silva T, Pires FQ, Cunha-Filho M, Gratieri T, Carvalho JL, Gelfuso GM (2022) Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia. Eur J Pharm Biopharm 172:78–88. https://doi.org/10.1016/j.ejpb.2022.02.00310.1016/j.ejpb.2022.02.003 ↗
23. Wu B, Li Y, Li YY, Shi ZH, Bian XH, Xia Q (2022) Nanostructured-lipid carriers-chitosan hydrogel beads carrier system for loading of resveratrol: a new method of topical application. J Biomater Appl 36(8):1444–1457. https://doi.org/10.1177/0885328221105392310.1177/08853282211053923 ↗
24. Sharma N, Kumar S, Joshi G, Choudhary D (2021) Formulation and characterization of febuxostat loaded nanostructured lipid carriers (NLCs) - gel for topical treatment of gout. Recent Pat Nanotechnol 16(3):250–258. https://doi.org/10.2174/187221051566621041511411810.2174/1872210515666210415114118 ↗
25. Rajpoot K, Prajapati SK, Malaiya A, Jain R, Jain A (2022) Meropenem-loaded nanostructured lipid carriers for skin and soft tissue infection caused by Staphylococcus aureus: formulation, design, and evaluation. AAPS PharmSciTech 23(7):241. https://doi.org/10.1208/s12249-022-02381-y10.1208/s12249-022-02381-y ↗
26. Ahmad Nasrollahi S, Koohestani F, Naeimifar A, Samadi A, Vatanara A, Firooz A (2021). Preparation and evaluation of adapalene nanostructured lipid carriers for targeted drug delivery in acne. Dermatol Ther 34(2). https://doi.org/10.1111/dth.1477710.1111/dth.14777 ↗
27. Patil A, Tuencar V, Gadad A, Dandagi P, Masareddy R (2021) Nanostructured lipid carrier-incorporated gel for efficient topical delivery of fluconazole. Ther Deliv 12(8):565–574. https://doi.org/10.4155/tde-2021-002910.4155/tde-2021-0029 ↗
28. Pereira MN, Tolentino S, Pires FQ, Anjos JLV, Alonso A, Gratieri T, … Gelfuso GM (2021) Nanostructured lipid carriers for hair follicle-targeted delivery of clindamycin and rifampicin to hidradenitis suppurativa treatment. Colloids Surf B Biointerfaces 197. https://doi.org/10.1016/j.colsurfb.2020.11144810.1016/j.colsurfb.2020.111448 ↗
29. Rapalli VK, Sharma S, Roy A, Singhvi G (2021) Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: a potential approach for improved permeation and prolong skin deposition. Colloids Surf B Biointerfaces 206. https://doi.org/10.1016/j.colsurfb.2021.11194510.1016/j.colsurfb.2021.111945 ↗
30. Cheon SH, Park SY, Sung J-H, Lee JG, Choi S-H, Jang J-W, … Jang D-J (2021) Preparation and evaluation of nanostructured lipid carrier for topical delivery of velutin: synthetic tyrosinase inhibitor. J Nanosci Nanotechnol 21(7):4093–4097. https://doi.org/10.1166/jnn.2021.1917310.1166/jnn.2021.19173 ↗
31. Youshia J, Kamel AO, El Shamy A, Mansour S (2021) Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs. Eur J Pharm Sci 163. https://doi.org/10.1016/j.ejps.2021.10588710.1016/j.ejps.2021.105887 ↗
32. Shaaban M, Nasr M, Tawfik AA, Fadel M, Sammour O (2021) Bergamot oil as an integral component of nanostructured lipid carriers and a photosensitizer for photodynamic treatment of vitiligo: characterization and clinical experimentation. Expert Opin Drug Deliv 18(1):139–150. https://doi.org/10.1080/17425247.2021.184418010.1080/17425247.2021.1844180 ↗
33. Khezri K, Saeedi M, Morteza-Semnani K, Akbari J, Hedayatizadeh-Omran A (2021) A promising and effective platform for delivering hydrophilic depigmenting agents in the treatment of cutaneous hyperpigmentation: kojic acid nanostructured lipid carrier. Artif Cells, Nanomed Biotechnol 49(1):38–47. https://doi.org/10.1080/21691401.2020.186599310.1080/21691401.2020.1865993 ↗
34. Rapalli VK, Kaul V, Waghule T, Gorantla S, Sharma S, Roy A, … Singhvi G (2020) Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. Eur J Pharm Sci 152. https://doi.org/10.1016/j.ejps.2020.10543810.1016/j.ejps.2020.105438 ↗
35. Madan JR, Khobaragade S, Dua K, Awasthi R (2020) Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast. Dermatol Ther 33(3). https://doi.org/10.1111/dth.1337010.1111/dth.13370 ↗
36. Ammar HO, Ghorab MM, Mostafa DM, Abd El-Alim SH, Kassem AA, Salah S, Shalaby ES (2020) Development of folic acid–loaded nanostructured lipid carriers for topical delivery: preparation, characterisation and ex vivo investigation. J Microencapsul 37(5):366–383. https://doi.org/10.1080/02652048.2020.176190410.1080/02652048.2020.1761904 ↗
37. Geng Q, Zhao Y, Wang L, Xu L, Chen X, Han J (2020) Development and evaluation of astaxanthin as nanostructure lipid carriers in topical delivery. AAPS PharmSciTech 21(8). https://doi.org/10.1208/s12249-020-01822-w10.1208/s12249-020-01822-w ↗
38. Na YG, Huh HW, Kim MK, Byeon JJ, Han MG, Lee HK, Cho CW (2020) Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes. Acta Biomater 101:507–518. https://doi.org/10.1016/j.actbio.2019.10.02410.1016/j.actbio.2019.10.024 ↗
39. Kesharwani P, Jain A, Srivastava AK, Keshari MK (2020) Systematic development and characterization of curcumin-loaded nanogel for topical application. Drug Dev Ind Pharm 1443–1457. https://doi.org/10.1080/03639045.2020.179399810.1080/03639045.2020.1793998 ↗
40. Patel P, Patel M (2020) Nanostructured lipid carriers- a versatile carrier for oral delivery of lipophilic drugs. Recent Pat Nanotechnol 15(2):154–164. https://doi.org/10.2174/187221051466620090915495910.2174/1872210514666200909154959 ↗
41. Poonia N, Kharb R, Lather V, Pandita D (2016) Nanostructured lipid carriers: versatile oral delivery vehicle. Futur Sci OA. https://doi.org/10.4155/fsoa-2016-003010.4155/fsoa-2016-0030 ↗
42. Subramaniam B, Siddik ZH, Nagoor NH (2020) Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. J Nanoparticle Res. https://doi.org/10.1007/s11051-020-04848-010.1007/s11051-020-04848-0 ↗
43. Alam T, Ansari MA, Baboota S, Ali J (2022) Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. Drug Deliv Transl Res 12(3):577–588. https://doi.org/10.1007/s13346-021-00958-x10.1007/s13346-021-00958-x ↗
44. Kataria D, Zafar A, Ali J, Khatoon K, Khan S, Imam SS, … Ali A (2022) Formulation of lipid-based nanocarriers of lacidipine for improvement of oral delivery: Box-Behnken design optimization, in vitro, ex vivo, and preclinical assessment. Assay Drug Dev Technol 20(1):5–21. https://doi.org/10.1089/adt.2021.08410.1089/adt.2021.084 ↗
45. Zewail M, EL-Deeb NM, Mousa MR, Abbas H (2022) Hyaluronic acid coated teriflunomide (A771726) loaded lipid carriers for the oral management of rheumatoid arthritis. Int J Pharm 623:121939. https://doi.org/10.1016/j.ijpharm.2022.12193910.1016/j.ijpharm.2022.121939 ↗
46. Gurumukhi VC, Bari SB (2022) Quality by design (QbD)–based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies. Drug Deliv Transl Res 12(5):1230–1252. https://doi.org/10.1007/s13346-021-01014-410.1007/s13346-021-01014-4 ↗
47. Sartaj A, Annu AM, Biswas L, Yar MS, Mir SR, ... Ali J (2022) Combinatorial delivery of ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising in silico, in vitro, and in vivo studies. J Drug Target.https://doi.org/10.1080/1061186X.2022.210429210.1080/1061186X.2022.2104292 ↗
48. Jitta SR, Bhaskaran NA, Salwa, Kumar L (2022) Anti-oxidant containing nanostructured lipid carriers of ritonavir: development, optimization, and in vitro and in vivo evaluations. AAPS PharmSciTech 23(4). https://doi.org/10.1208/s12249-022-02240-w10.1208/s12249-022-02240-w ↗
49. Sharma T, Katare OP, Jain A, Jain S, Chaudhari D, Borges B, Singh B (2021) QbD-steered development of biotin-conjugated nanostructured lipid carriers for oral delivery of chrysin: role of surface modification for improving biopharmaceutical performance. Colloids Surf B Biointerfaces 197. https://doi.org/10.1016/j.colsurfb.2020.11142910.1016/j.colsurfb.2020.111429 ↗
50. Sharma M, Chaudhary D (2021) Exploration of bromelain laden nanostructured lipid carriers: an oral platform for bromelain delivery in rheumatoid arthritis management. Int J Pharm 594. https://doi.org/10.1016/j.ijpharm.2020.12017610.1016/j.ijpharm.2020.120176 ↗
51. Saghafi Z, Mohammadi M, Mahboobian MM, Derakhshandeh K (2021) Preparation, characterization, and in vivo evaluation of perphenazine-loaded nanostructured lipid carriers for oral bioavailability improvement. Drug Dev Ind Pharm 47(3):509–520. https://doi.org/10.1080/03639045.2021.189274510.1080/03639045.2021.1892745 ↗
52. Elkomy MH, Elmowafy M, Shalaby K, Azmy AF, Ahmad N, Zafar A, Eid HM (2021) Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis. Drug Dev Ind Pharm 47(2):246–258. https://doi.org/10.1080/03639045.2020.187100510.1080/03639045.2020.1871005 ↗
53. Agarwal S, HariKumar SL, Negi P, Upadhyay N, Garg R (2020) Quetiapine fumarate loaded nanostructured lipid carrier for enhancing oral bioavailability: design, development and pharmacokinetic assessment. Curr Drug Deliv 18(2):184–198. https://doi.org/10.2174/156720181799920072813511910.2174/1567201817999200728135119 ↗
54. Patel P, Patel M (2021). Enhanced oral bioavailability of nintedanib esylate with nanostructured lipid carriers by lymphatic targeting: in vitro, cell line and in vivo evaluation. Eur J Pharm Sci 159. https://doi.org/10.1016/j.ejps.2021.10571510.1016/j.ejps.2021.105715 ↗
55. Khan AS, ud Din F, Ali Z, Bibi M, Zahid F, Zeb A, … Khan GM (2021) Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of cutaneous Leishmaniasis. Int J Pharm 593. https://doi.org/10.1016/j.ijpharm.2020.12010910.1016/j.ijpharm.2020.120109 ↗
56. Zhu Y, Liang X, Lu C, Kong Y, Tang X, Zhang Y, … He H (2020) Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorption. Int J Pharm 586. https://doi.org/10.1016/j.ijpharm.2020.11956910.1016/j.ijpharm.2020.119569 ↗
57. Soni NK, Sonali LJ, Singh A, Mangla B, Neupane YR, Kohli K (2020). Nanostructured lipid carrier potentiated oral delivery of raloxifene for breast cancer treatment. Nanotechnology 31(47). https://doi.org/10.1088/1361-6528/abaf8110.1088/1361-6528/abaf81 ↗
58. Pyo YC, Tran P, Kim DH, Park JS (2020) Chitosan-coated nanostructured lipid carriers of fenofibrate with enhanced oral bioavailability and efficacy. Colloids Surf B Biointerfaces 196. https://doi.org/10.1016/j.colsurfb.2020.11133110.1016/j.colsurfb.2020.111331 ↗
59. Dong Z, Iqbal S, Zhao Z (2020). Preparation of ergosterol-loaded nanostructured lipid carriers for enhancing oral bioavailability and antidiabetic nephropathy effects. AAPS PharmSciTech 21(2). https://doi.org/10.1208/s12249-019-1597-310.1208/s12249-019-1597-3 ↗
60. Tirumalesh C, Suram D, Dudhipala N, Banala N (2020) Enhanced pharmacokinetic activity of zotepine via nanostructured lipid carrier system in Wistar rats for oral application. Pharm Nanotechnol 8(2):148–160. https://doi.org/10.2174/221173850866620022511335910.2174/2211738508666200225113359 ↗
61. Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci. https://doi.org/10.1038/nrn311410.1038/nrn3114 ↗
62. Fonseca LC, Lopes JA, Vieira J, Viegas C, Oliveira CS, Hartmann RP, Fonte P (2021) Intranasal drug delivery for treatment of Alzheimer’s disease. Drug Deliv Transl Res 11(2):411–425. https://doi.org/10.1007/s13346-021-00940-710.1007/s13346-021-00940-7 ↗
63. Patel RJ, Parikh RH (2020) Intranasal delivery of topiramate nanoemulsion: pharmacodynamic, pharmacokinetic and brain uptake studies. Int J Pharm 585. https://doi.org/10.1016/j.ijpharm.2020.11948610.1016/j.ijpharm.2020.119486 ↗
64. Reddy S, Tatiparti K, Sau S, Iyer AK (2021) Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors. Drug Discov Today. https://doi.org/10.1016/j.drudis.2021.04.00810.1016/j.drudis.2021.04.008 ↗
65. Parikh RH, Patel RJ (2017) Nanoemulsions for intranasal delivery of riluzole to improve brain bioavailability: formulation development and pharmacokinetic studies. Curr Drug Deliv 13(7):1130–1143. https://doi.org/10.2174/156720181366615120219572910.2174/1567201813666151202195729 ↗
66. Agrawal M, Pradhan M, Singhvi G, Patel R, Ajazuddin, Alexander A (2022) Thermoresponsive in situ gel of curcumin loaded solid lipid nanoparticle: design, optimization and in vitro characterization. J Drug Deliv Sci Technol 71. https://doi.org/10.1016/j.jddst.2022.10337610.1016/j.jddst.2022.103376 ↗
67. Patel AA, Patel RJ, Patel SR (2017) Nanomedicine for intranasal delivery to improve brain uptake. Curr Drug Deliv 14. https://doi.org/10.2174/156720181466617101315053410.2174/1567201814666171013150534 ↗
68. Pardeshi CV, Belgamwar VS (2013) Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv. https://doi.org/10.1517/17425247.2013.79088710.1517/17425247.2013.790887 ↗
69. Cunha S, Swedrowska M, Bellahnid Y, Xu Z, Sousa Lobo JM, Forbes B, Silva AC (2022) Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies. Int J Pharm 620:121720. https://doi.org/10.1016/j.ijpharm.2022.12172010.1016/j.ijpharm.2022.121720 ↗
70. Mathure D, Ranpise H, Awasthi R, Pawar A (2022) Formulation and characterization of nanostructured lipid carriers of rizatriptan benzoate-loaded in situ nasal gel for brain targeting. Assay Drug Dev Technol 20(5):211–224. https://doi.org/10.1089/adt.2022.04410.1089/adt.2022.044 ↗
71. Markova E, Taneska L, Kostovska M, Shalabalija D, Mihailova L, Glavas Dodov M, … Simonoska Crcarevska M (2022) Design and evaluation of nanostructured lipid carriers loaded with Salvia officinalis extract for Alzheimer’s disease treatment. J Biomed Mater Res-Part B Appl Biomater 110(6):1368–1390. https://doi.org/10.1002/jbm.b.3500610.1002/jbm.b.35006 ↗
72. Gadhave D, Rasal N, Sonawane R, Sekar M, Kokare C (2021) Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: pharmacological and in vitro cytotoxicity studies. Int J Biol Macromol 167:906–920. https://doi.org/10.1016/j.ijbiomac.2020.11.04710.1016/j.ijbiomac.2020.11.047 ↗
73. Kaur S, Nautiyal U, Chawla PA, Chawla V (2021) Nanostructured lipid carriers for intranasal administration of olanzapine in the management of schizophrenia. Curr Mol Pharmacol 14(3):439–447. https://doi.org/10.2174/187446721466621012016001610.2174/1874467214666210120160016 ↗
74. Gautam D, Singh S, Maurya P, Singh M, Kushwaha S, Saraf SA (2021) Appraisal of nano-lipidic astaxanthin cum thermoreversible gel and its efficacy in haloperidol induced Parkinsonism. Curr Drug Deliv 18(10):1550–1562. https://doi.org/10.2174/156720181866621051017352410.2174/1567201818666210510173524 ↗
75. Masjedi M, Azadi A, Heidari R, Mohammadi-Samani S (2020) Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation. J Pharm Pharmacol 72(10):1341–1351. https://doi.org/10.1111/jphp.1331610.1111/jphp.13316 ↗
76. Salem LH, El-Feky GS, Fahmy RH, El Gazayerly ON, Abdelbary A (2020) Coated lipidic nanoparticles as a new strategy for enhancing nose-to-brain delivery of a hydrophilic drug molecule. J Pharm Sci 109(7):2237–2251. https://doi.org/10.1016/j.xphs.2020.04.00710.1016/j.xphs.2020.04.007 ↗
77. Du W, Li H, Tian B, Sai S, Gao Y, Lan T, … Ding C (2019) Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice. Colloids Surf B Biointerfaces 183. https://doi.org/10.1016/j.colsurfb.2019.11044610.1016/j.colsurfb.2019.110446 ↗
78. Gadhave DG, Kokare CR (2019) Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies. Drug Dev Ind Pharm 45(5):839–851. https://doi.org/10.1080/03639045.2019.157672410.1080/03639045.2019.1576724 ↗
79. Gadhave DG, Tagalpallewar AA, Kokare CR (2019) Agranulocytosis-protective olanzapine-loaded nanostructured lipid carriers engineered for CNS delivery: optimization and hematological toxicity studies. AAPS PharmSciTech 20(1). https://doi.org/10.1208/s12249-018-1213-y10.1208/s12249-018-1213-y ↗
80. Mishra N, Sharma S, Deshmukh R, Kumar A, Sharma R (2018) Development and characterization of nasal delivery of selegiline hydrochloride loaded nanolipid carriers for the management of Parkinson’s disease. Cent Nerv Syst Agents Med Chem 19(1):46–56. https://doi.org/10.2174/187152491966618112612484610.2174/1871524919666181126124846 ↗
81. Jojo GM, Kuppusamy G, De A, Karri VVSNR (2019) Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer’s disease using Box-Behnken design. Drug Dev Ind Pharm 45(7):1061–1072. https://doi.org/10.1080/03639045.2019.159343910.1080/03639045.2019.1593439 ↗
82. Wavikar P, Pai R, Vavia P (2017) Nose to brain delivery of rivastigmine by in situ gelling cationic nanostructured lipid carriers: enhanced brain distribution and pharmacodynamics. J Pharm Sci 106(12):3613–3622. https://doi.org/10.1016/j.xphs.2017.08.02410.1016/j.xphs.2017.08.024 ↗
83. Gartziandia O, Herrán E, Ruiz-Ortega JA, Miguelez C, Igartua M, Lafuente JV, … Hernández RM (2016) Intranasal administration of chitosan-coated nanostructured lipid carriers loaded with GDNF improves behavioral and histological recovery in a partial lesion model of Parkinson’s disease. J Biomed Nanotechnol 12(12):2220–2230. https://doi.org/10.1166/jbn.2016.231310.1166/jbn.2016.2313 ↗
84. Wavikar PR, Vavia PR (2015) Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery. J Liposome Res 25(2):141–149. https://doi.org/10.3109/08982104.2014.95412910.3109/08982104.2014.954129 ↗
85. Gartziandia O, Herran E, Pedraz JL, Carro E, Igartua M, Hernandez RM (2015) Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration. Colloids Surf B Biointerfaces 134:304–313. https://doi.org/10.1016/j.colsurfb.2015.06.05410.1016/j.colsurfb.2015.06.054 ↗
86. Devkar TB, Tekade AR, Khandelwal KR (2014) Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer. Colloids Surf B Biointerfaces 122:143–150. https://doi.org/10.1016/j.colsurfb.2014.06.03710.1016/j.colsurfb.2014.06.037 ↗
87. Alam MI, Baboota S, Ahuja A, Ali M, Ali J, Sahni JK, Bhatnagar A (2014) Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug. Int J Pharm 470(1–2):99–106. https://doi.org/10.1016/j.ijpharm.2014.05.00410.1016/j.ijpharm.2014.05.004 ↗
88. Gabal YM, Kamel AO, Sammour OA, Elshafeey AH (2014) Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Int J Pharm 473(1–2):442–457. https://doi.org/10.1016/j.ijpharm.2014.07.02510.1016/j.ijpharm.2014.07.025 ↗
89. Jain K, Sood S, Gowthamarajan K (2015) Optimization of artemether-loaded NLC for intranasal delivery using central composite design. Drug Deliv 22(7):940–954. https://doi.org/10.3109/10717544.2014.88599910.3109/10717544.2014.885999 ↗
90. Alam MI, Baboota S, Ahuja A, Ali M, Ali J, Sahni JK (2013) Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood. Drug Deliv 20(6):247–251. https://doi.org/10.3109/10717544.2013.82294510.3109/10717544.2013.822945 ↗
91. Alam T, Pandit J, Vohora D, Aqil M, Ali A, Sultana Y (2015) Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert Opin Drug Deliv 12(2):181–194. https://doi.org/10.1517/17425247.2014.94541610.1517/17425247.2014.945416 ↗
92. Amendola V, Guadagnini A, Agnoli S, Badocco D, Pastore P, Fracasso G, … Marzola P (2021). Polymer-coated silver-iron nanoparticles as efficient and biodegradable MRI contrast agents. J Colloid Interface Sci 596:332–341. https://doi.org/10.1016/j.jcis.2021.03.09610.1016/j.jcis.2021.03.096 ↗
93. Miao Z, Chen S, Xu CY, Ma Y, Qian H, Xu Y, … Zha Z (2019). PEGylated rhenium nanoclusters: a degradable metal photothermal nanoagent for cancer therapy. Chem Sci 10(21):5435–5443. https://doi.org/10.1039/c9sc00729f10.1039/c9sc00729f ↗
94. Khan I, Hussein S, Houacine C, Khan Sadozai S, Islam Y, Bnyan R, … Yousaf S (2021) Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers. Int J Pharm 598. https://doi.org/10.1016/j.ijpharm.2021.12037610.1016/j.ijpharm.2021.120376 ↗
95. Maaz A, Blagbrough IS, De Bank PA (2021) In vitro evaluation of nasal aerosol depositions: an insight for direct nose to brain drug delivery. Pharmaceutics 13(7):1079. https://doi.org/10.3390/pharmaceutics1307107910.3390/pharmaceutics13071079 ↗
96. Almurshedi AS, Aljunaidel HA, Alquadeib B, Aldosari BN, Alfagih IM, Almarshidy SS, … Mohamoud AZ (2021) Development of inhalable nanostructured lipid carriers for ciprofloxacin for noncystic fibrosis bronchiectasis treatment. Int J Nanomed 16:2405–2417. https://doi.org/10.2147/IJN.S28689610.2147/IJN.S286896 ↗
97. Patil-Gadhe A, Pokharkar V (2016) Pulmonary targeting potential of rosuvastatin loaded nanostructured lipid carrier: optimization by factorial design. Int J Pharm 501(1–2):199–210. https://doi.org/10.1016/j.ijpharm.2016.01.08010.1016/j.ijpharm.2016.01.080 ↗
98. Patil-Gadhe A, Kyadarkunte A, Patole M, Pokharkar V (2014) Montelukast-loaded nanostructured lipid carriers: part II Pulmonary drug delivery and in vitro-in vivo aerosol performance. Eur J Pharm Biopharm 88(1):169–177. https://doi.org/10.1016/j.ejpb.2014.07.00710.1016/j.ejpb.2014.07.007 ↗
99. Murthy RSR, Khattar H, Singh S (2012) Formulation and characterization of nano lipid carrier dry powder inhaler containing ciprofloxacin hydrochloride and N-acetyl cysteine. Int J Drug Deliv 4(3). https://doi.org/10.5138/ijdd.v4i3.64710.5138/ijdd.v4i3.647 ↗
100. Pardeike J, Weber S, Haber T, Wagner J, Zarfl HP, Plank H, Zimmer A (2011) Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm. https://doi.org/10.1016/j.ijpharm.2011.07.04010.1016/j.ijpharm.2011.07.040 ↗